Tag: BioSig

Clinical Data Acquired by the PURE EP™ System Published in the Journal of Cardiac Electrophysiology

The PURE EP™ System is validated in multi-center study as superior to conventional sources of intracardiac signals Westport, CT, Oct. 04, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal fidelity and […]

BioSig Selects Plexus Corp. as its Manufacturing Partner

Global leader in complex product design, supply chain, manufacturing, and aftermarket services to support the Company’s growth Westport, CT, Sept. 28, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity […]

BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors

James J. Barry, Ph.D. will join as an Independent Director as Company expands clinical footprint with its signal processing technology for arrhythmia care Westport, CT, Sept. 21, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform […]

BioSig Increases Installation Footprint Adding St. Elizabeth’s Medical Center to Roster of Premium Medical Institutions Utilizing the PURE EP System

The Company expands into exploration of its novel signal processing technology in physiologic pacing procedures Westport, CT, Sept. 13, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]

BioSig Confirmed as a Participant of The Mark E. Josephson Twenty-Eight Annual State-of-the-Art Arrhythmia Virtual Symposium

Physician-only event, organized by the University of Pennsylvania, is a tribute to the pioneer of cardiac electrophysiology Westport, CT, Aug. 31, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and […]

BioSig’s Signal Processing System for Arrhythmia Care To Be Featured At The Kansas City Heart Rhythm Symposium

A physician user from a leading medical center of excellence will present the technology and discuss recent clinical data Westport, CT, Aug. 19, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve […]

BioSig Latest Installation Broadens Clinical Footprint for its Signal Processing Technology for Electrophysiology

Texas installation builds as company adds team members to support installations around major metropolitan areas Westport, CT, July 13, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]

BioSig Announces Closing of Public Offering of Common Stock

Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the completion of its previously […]

BioSig Enters the New York Market with Its Signal Processing Technology for Electrophysiology

The Company installs its novel medical technology platform for arrhythmia care in a leading Center of Excellence Westport, CT, July 07, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and […]

BioSig Announces Pricing of Public Offering of Common Stock

Westport, CT, July 02, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced pricing of its previously announced […]